Literature DB >> 20531313

Firms chase diabetic inflammation with anti-IL-1beta antibodies.

Cormac Sheridan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531313     DOI: 10.1038/nbt0610-533

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.

Authors:  Allison B Goldfine; Vivian Fonseca; Kathleen A Jablonski; Laura Pyle; Myrlene A Staten; Steven E Shoelson
Journal:  Ann Intern Med       Date:  2010-03-16       Impact factor: 25.391

2.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

3.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Authors:  Peter Duewell; Hajime Kono; Katey J Rayner; Cherilyn M Sirois; Gregory Vladimer; Franz G Bauernfeind; George S Abela; Luigi Franchi; Gabriel Nuñez; Max Schnurr; Terje Espevik; Egil Lien; Katherine A Fitzgerald; Kenneth L Rock; Kathryn J Moore; Samuel D Wright; Veit Hornung; Eicke Latz
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

Review 4.  The NLRP3 inflammasome: a sensor for metabolic danger?

Authors:  Kate Schroder; Rongbin Zhou; Jurg Tschopp
Journal:  Science       Date:  2010-01-15       Impact factor: 47.728

5.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Aage Vølund; Jan A Ehses; Burkhardt Seifert; Thomas Mandrup-Poulsen; Marc Y Donath
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

6.  Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Jan A Ehses; Marc Y Donath; Thomas Mandrup-Poulsen
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.